NO to Breast: When, Why and Why Not?

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|16|4|451-462

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.16, Iss.4, 2010-02, pp. : 451-462

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prediction of warfarin dose: why, when and how?

By Eriksson Niclas   Wadelius Mia  

Pharmacogenomics, Vol. 13, Iss. 4, 2012-03 ,pp. : 429-440

Future Medicine

Access to resources Recommend Favorite

Gamma-Secretase as a Pharmacological Target in Alzheimer Disease Research: When, Why and How?

By  

Current Pharmaceutical Design, Vol. 12, Iss. 33, 2006-11 ,pp. : 4313-4335

Bentham Science Publishers

Access to resources Recommend Favorite

Unique/Major Human Metabolites: Why, How, and When to Test for Safety in Animals

By Luffer-Atlas Debra  

Drug Metabolism Reviews, Vol. 40, Iss. 3, 2008-07 ,pp. : 447-463

Informa Healthcare

Access to resources Recommend Favorite

Why Should We Keep the Cerebellum in Mind When Thinking About Addiction?

By  

Current Drug Abuse Reviews, Vol. 2, Iss. 1, 2009-01 ,pp. : 26-40

Bentham Science Publishers

Access to resources Recommend Favorite

Why Do We Believe that Breast Cancer in the Elderly is the Same as Breast Cancer in Young Women?

By Hughes Kevin S.  

Drugs & Aging, Vol. 25, Iss. 1, 2008-01 ,pp. : 47-48

Adis International

Access to resources Recommend Favorite